Trial Profile
Predictive factor analysis for treatment of Ulcerative Colitis with Tofacitinib
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2018
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Ulcerative colitis
- Focus Biomarker; Therapeutic Use
- 03 Dec 2018 New trial record